RT @OxBioDynamics: Using our #EpiSwitch platform, we developed an enhanced screening approach for #prostatecancer based on 3D genomics. Lea…
Using our #EpiSwitch platform, we developed an enhanced screening approach for #prostatecancer based on 3D genomics. Learn more in our publication with top clinical experts from @imperialcollege @NNUH @UeaMed at https://t.co/qbBq6aVv1W. #EpiSwitchON https:
As #ProstateCancerAwarenessMonth draws to a close in the UK, we remain committed to helping improve #earlydectection. Learn about our novel approach to #prostatecancer screening published with top clinical experts from @imperialcollege @NNUH @UeaMed at htt
Chromatin conformation changes in peripheral blood can detect prostate cancer and stratify disease risk groups https://t.co/XzYS86qq25 #Chromatin #prostatecancerdiagnosis #becausescienceishard https://t.co/YSK0NLvWFt